ISRCTN83027184已完成不适用
A randomised trial of Myfortic® versus mycophenolate in the treatment of multisystem autoimmune disease
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Diagnosis of Systemic Lupus Erythematosus (SLE) or Primary Systemic Vasculitis (PSV)
- •2. Either:
- •a. About to commence MMF or
- •b. Established on MMF for at least three months but with inadequate disease control on MMF 2000 mg per day or less
- •c. Written informed consent
排除标准
- •1. Active infection (including hepatitis B, C, Human Immunodeficiency Virus [HIV] and tuberculosis)
- •2. Known hypersensitivity to MMF
- •3. Cancer or an individual history of cancer (other than resected basal cell skin carcinoma)
- •4. Females who are pregnant, breast feeding, or at risk of pregnancy and not using a medically acceptable form of contraception
- •5. Any condition judged by the investigator that would cause the study to be detrimental to the patient
- •6. Use of any investigational drug within four weeks of the baseline visit
- •7. Patients who are planning to undergo elective surgery during the study period
- •8.Age <18 years
研究者
相似试验
进行中（未招募）
1 期
A randomised controlled trial of Myfortic versus Mycophenolate Mofetil in the treatment of multi-system autoimmune disease. - MYFMADMulti-system autoimmune diseases including vasculitis and systemic lupus erythematosus (SLE)EUCTR2005-002207-16-GBCambridge University Hospitals NHS Foundation Trust40
进行中（未招募）
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCAnti neutrophil cytoplasmic antibody (ANCA) associated vasculitisEUCTR2006-001663-33-DECambridge University Hospitals NHS Foundation Trust140
进行中（未招募）
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCAnti neutrophil cytoplasmic antibody (ANCA) associated vasculitis. Wegener´s granulomatosis (WG) and microscopic polyangiitis (MPA) are primary systemic vasculitides associated with ANCAEUCTR2006-001663-33-SECambridge University Hospitals NHS Foundation Trust140
进行中（未招募）
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis. - MYCYCPatient ayant une vascularite associée aux ANCAMedDRA version: 8.1Level: PTClassification code 10047115Term: VasculitisEUCTR2006-001663-33-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)140
进行中（未招募）
1 期
A randomised clinical trial of mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis - MYCYCEUCTR2006-001663-33-GBCambridge University Hospitals NHS Foundation Trust140